Literature DB >> 3338372

Prolonged jaundice following ketoconazole-induced hepatic injury.

G D Benson1, P K Anderson, B Combes, K G Ishak.   

Abstract

Two patients developed prolonged and progressive jaundice associated with ketoconazole-induced hepatic injury although the drug was discontinued before or shortly after the onset of symptoms of hepatic toxicity. One patient, who had been jaundiced for eight weeks and was not improving, showed prompt clinical improvement and progressive resolution of jaundice following therapy with prednisolone. Liver biopsy before therapy showed marked cholestasis in all acinar zones and moderately severe fibrosis in the space of Disse. The other patient, who was less severely jaundiced, showed spontaneous resolution although he remained jaundiced for 11 weeks. Liver biopsy performed three weeks after onset of symptoms showed a moderate degree of cholestasis in acinar zone 3 and collagen deposition about the terminal hepatic venules and within the space of Disse. These cases are reported because of the unique clinical course, documentation of the morphologic features, and experience with corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3338372     DOI: 10.1007/bf01535739

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  9 in total

Review 1.  Drug-induced chronic liver disease.

Authors:  W C Maddrey; J K Boitnott
Journal:  Gastroenterology       Date:  1977-06       Impact factor: 22.682

2.  Hepatic reactions during ketoconazole treatment.

Authors:  P A Janssen; J E Symoens
Journal:  Am J Med       Date:  1983-01-24       Impact factor: 4.965

3.  Toxic hepatis during ketoconazole treatment.

Authors:  J K Heiberg; E Svejgaard
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-26

Review 4.  Corticosteroid therapy for chronic active hepatitis.

Authors: 
Journal:  Am J Gastroenterol       Date:  1984-07       Impact factor: 10.864

5.  Hepatic toxicity of ketoconazole.

Authors:  O Rollman; L Lööf
Journal:  Br J Dermatol       Date:  1983-03       Impact factor: 9.302

6.  Fatal hepatitis associated with ketoconazole therapy.

Authors:  P A Duarte; C C Chow; F Simmons; J Ruskin
Journal:  Arch Intern Med       Date:  1984-05

7.  Ketoconazole-induced fulminant hepatitis.

Authors:  E Bercoff; J Bernuau; C Degott; B Kalis; A Lemaire; H Tilly; B Rueff; J P Benhamou
Journal:  Gut       Date:  1985-06       Impact factor: 23.059

8.  Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin.

Authors:  J R Sharp; K G Ishak; H J Zimmerman
Journal:  Ann Intern Med       Date:  1980-01       Impact factor: 25.391

9.  Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases.

Authors:  J H Lewis; H J Zimmerman; G D Benson; K G Ishak
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

  9 in total
  4 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

Review 2.  Drug-induced liver injury: is it somehow foreseeable?

Authors:  Giovanni Tarantino; Matteo Nicola Dario Di Minno; Domenico Capone
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

Review 3.  The treatment of advanced prostate cancer with ketoconazole: safety issues.

Authors:  R A Bok; E J Small
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.228

4.  Enantiospecific effects of ketoconazole on aryl hydrocarbon receptor.

Authors:  Aneta Novotna; Martina Korhonova; Iveta Bartonkova; Anatoly A Soshilov; Michael S Denison; Katerina Bogdanova; Milan Kolar; Petr Bednar; Zdenek Dvorak
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.